OTCMKTS:VRSSF VERSES AI (VRSSF) Stock Price, News & Analysis → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free VRSSF Stock Alerts 0.67 -0.07 (-9.50%) (As of 06:30 PM ET) Add Compare Share Share Today's Range0.66▼0.7550-Day Range0.75▼1.3152-Week Range0.56▼2.78Volume234,700 shsAverage Volume301,580 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get VERSES AI alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About VERSES AI Stock (OTCMKTS:VRSSF)VERSES AI Inc., a cognitive computing company, engages in the development of artificial intelligence (AI) software. The company offers KOSM, a network operating system for enabling distributed intelligence; and Wayfinder, an AI assisted order picking solution. It is also developing GIA, an AI powered personal assistant for everyone. The company was formerly known as Verses Technologies Inc. and changed its name to VERSES AI Inc. in March 2023. VERSES AI Inc. was incorporated in 2020 and is headquartered in Columbia, Canada.Read More VRSSF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VRSSF Stock News HeadlinesApril 18, 2024 | globenewswire.comVERSES Announces Private Placement of Special Warrants and Closing of First TrancheApril 18, 2024 | msn.comAI vs. Humanity — Why Humans Will Always Win in Content CreationApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 15, 2024 | globenewswire.comVERSES Provides Q1 2024 Corporate UpdateApril 12, 2024 | msn.comTop Reasons Global AI Governance Is Exceedingly CrucialApril 12, 2024 | globenewswire.comVERSES Advances Spatial Web Protocol, Architecture and Governance Standards to Final Voting StageApril 11, 2024 | bloomberg.comThis Startup Is Trying to Test How Well AI Models Actually WorkApril 9, 2024 | msn.comAI vs humans: Influencers face competition from virtual modelsApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.March 30, 2024 | cnet.comExpert vs. AI: CNET's New Series Pits Our Knowledge Against ChatbotsMarch 18, 2024 | baystreet.caFive Top Artificial Intelligence Stocks You May Regret Not Buying TodayMarch 18, 2024 | globenewswire.comVERSES Names Analog CEO Alex Kipman as Strategic Advisor & Closes US$2M InvestmentMarch 16, 2024 | msn.comIndia vs AI risks: Breather for big digital platforms on AI models deployment, but here's here's the catchMarch 12, 2024 | msn.comAI vs Expert: Analyzing SECURE 2.0 Saver's Match AdviceMarch 8, 2024 | forbes.comAI Vs. AI: How To Win The Corporate Cybersecurity BattleMarch 7, 2024 | msn.comFive Top Game-Changing AI Stocks to Buy and Hold TodayMarch 7, 2024 | finance.yahoo.comVERSES AI Announces Blue Yonder Joins the Genius™ Beta ProgramFebruary 28, 2024 | globenewswire.comVERSES AI Webinar Announcement: an Overview of AI BenchmarkingFebruary 24, 2024 | msn.comStreamlining AI for precise medical summarizationFebruary 22, 2024 | theglobeandmail.comFive of the Top Artificial Intelligence Stocks to Invest in ImmediatelyFebruary 22, 2024 | finance.yahoo.comVERSES Challenges AI Industry with Benchmark TestsFebruary 22, 2024 | globenewswire.comVERSES Challenges AI Industry with Benchmark TestsFebruary 8, 2024 | finance.yahoo.comVERSES to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference on February 13 - 15, 2024February 1, 2024 | baystreet.caFive of the Top AI Stocks That Will Help Lead the Bull Market in TechFebruary 1, 2024 | finance.yahoo.comVERSES Brings Natural Computing to the Center of AI Discussions on the World Stage at Davos 2024January 31, 2024 | msn.comAdopting generative AI to drive softwarization of automobilesJanuary 19, 2024 | msn.comVerses and Analog join hands to develop smart city infrastructure for UAESee More Headlines Receive VRSSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VERSES AI and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorComputer and Technology Industry Software - Infrastructure Sub-IndustryN/A Current SymbolOTCMKTS:VRSSF CUSIPN/A CIKN/A Webwww.verses.ai Phone323-868-0514FaxN/AEmployees32Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesGabriel ReneFounder, CEO & DirectorDan MapesFounder, President & DirectorMr. Kevin Wilson (Age 65)Chief Financial Officer Dr. Karl FristonChief ScientistSteven SwansonChief Administration OfficerCapm PetersenChief Innovation OfficerMichael WaddenChief Commercial OfficerPhilippe SayeghChief Adoption OfficerMr. James HendricksonPresident & GM of Verses EnterpriseMore ExecutivesKey CompetitorsAdyenOTCMKTS:ADYYFAEyeNASDAQ:LIDRWAfterpayOTCMKTS:AFTPFAirship AINASDAQ:AISPWAppTech PaymentsNASDAQ:APCXWView All Competitors VRSSF Stock Analysis - Frequently Asked Questions How have VRSSF shares performed in 2024? VERSES AI's stock was trading at 1.15 at the start of the year. Since then, VRSSF shares have decreased by 35.2% and is now trading at 0.75. View the best growth stocks for 2024 here. How do I buy shares of VERSES AI? Shares of VRSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:VRSSF) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VERSES AI Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.